Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
New Managing Director for LANXESS in India - The Pharma Times | Pharma & Health Care News Portal
Financial Results

New Managing Director for LANXESS in India

Neelanjan Banerjee succeeds Jacques Perez

Thane, July 24, 2018: Neelanjan Banerjee, age 45 years, will be the new Country Representative and Managing Director for India effective September 1, 2018. He will assume these tasks in addition to his current function as head of the Advanced Industrial Intermediates business unit (BU AII) in India. Banerjee joined LANXESS in 2006 as head of the former Basic Chemicals business unit and the Saltigo business unit in India.

Banerjee follows Jacques Perez, age 56 years, who  will take over new responsibilities as Managing Director of LANXESS Holding UK Unlimited and Country Representative of LANXESS in the United Kingdom. Born in France, he has also held the position of Chief Financial Officer (CFO) of LANXESS India Private Limited since 2013.

“On behalf of the entire Board of Management, I would like to thank both Jacques Perez and Neelanjan Banerjee for their excellent work and outstanding contributions to the company so far and wish them every success in their new roles” said Rainier van Roessel, Member of the Board of Management at LANXESS AG, commenting on the development.

LANXESS in India

LANXESS India was incorporated in India on February 20, 2004, and is represented through all its twelve business units, operating out of its registered office in Thane and sales offices in New Delhi and Chennai with around 1000 employees across its operations.

The company also has manufacturing facilities in India for five of its business units. The manufacturing sites are located in Nagda in Madhya Pradesh and Jhagadia in Gujarat. Production facilities for business units Liquid Purification Technologies (ion exchange resins), High Performance Materials (high tech plastics), Material Protection Products (biocides) and RheinChemie (polymer bound rubber chemicals and release agents) are operational in Jhagadia. The business unit Advanced Industrial Intermediates has production facilities both in Nagda and Jhagadia.

LANXESS has invested a sizeable amount in India over the years, in greenfield investments, acquisitions and in upgradation of assets, which validates the potential of the Indian chemical industry.

For more information on LANXESS India please go to www.lanxess.in

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

2 days ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

4 days ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

2 weeks ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

2 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

3 weeks ago

Ankura Hospital Doctors perform a successful Complex Lung Surgery on a 4-month-old Infant

 Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…

3 weeks ago